Table 1.
 Description of groups at trial entry. Figures are number (percentage*) unless stated otherwise
| Randomised participants | Preference participants | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical | Medical | Surgical | Medical | ||||||||
| ITT (n=178) | PP (n=111) | ITT (n=179) | PP (n=169) | ITT (n=261) | PP (n=218) | ITT (n=192) | PP (n=189) | ||||
| Baseline questionnaire returned | 175 (98) | 111 (100) | 174 (97) | 165 (98) | 256 (98) | 216 (99) | 189 (98) | 186 (98) | |||
| Mean (SD) age (years) | 46.7 (10.3) | 46.3 (10.2) | 45.9 (11.9) | 45.9 (11.9) | 44.4 (12.0) | 44.5 (12.2) | 49.9 (11.8) | 50 (11.7) | |||
| Men | 116 (65) | 68 (61) | 120 (67) | 115 (68) | 170 (65) | 139 (64) | 111 (58) | 110 (58) | |||
| Mean (SD) BMI | 28.5 (4.3) | 28.7 (4.1) | 28.4 (4.0) | 28.3 (4.0) | 27.7 (4.0) | 27.5 (3.7) | 27.4 (4.1) | 27.4 (4.1) | |||
| Median duration (months) of prescribed medication for GORD (IQR) | 33 (15-83) | 30 (16-76) | 31 (16-71) | 30 (15-71) | 35 (14-71) | 36 (14-65) | 27 (13-60) | 26.5 (13-60) | |||
| In full time paid employment | 116 (66) | 72 (66) | 110 (62) | 104 (62) | 168 (65) | 138 (64) | 100 (52) | 97 (52) | |||
| Current smoker | 46 (26) | 29 (26) | 40 (22) | 36 (21) | 71 (27) | 61 (28) | 39 (20) | 39 (21) | |||
ITT=intention to treat; PP=per protocol; BMI=body mass index; IQR=interquartile range.
*Calculated excluding missing data from returned forms.